Home
About
Overview
Sharing Data
ORCID
Help
History (9)
What's best for IBS?
ANTIBODY-INDUCED GLOMERULAR BASEMENT MEMBRANE INJURY
Incidence of serious bleeding events (sBE) in patients (pts) with metastatic colorectal cancer (mCRC) receiving bevacizumab (BV) as part of a first-line regimen: Results from the BRiTE observational cohort study (OCS).
Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients (pts) with metastatic colorectal cancer (mCRC): Results from the BRiTE observational cohort study.
Principal Investigator
See All 9 Pages
Find People
Find Everything
Edit My Profile
My Person List (
0
)
Return to Top
Login
Username
Password